Conventional, regulatory, and unconventional T cells in the immunologic response to Helicobacter pylori

被引:42
作者
O'Keeffe, Joan [2 ]
Moran, Anthony P. [1 ]
机构
[1] Natl Univ Ireland Univ Coll Galway, Dept Microbiol, Galway, Ireland
[2] Natl Univ Ireland Univ Coll Galway, Dept Biochem, Galway, Ireland
关键词
Helicobacter pylori; immune response; T helper cells; regulatory T cells; innate T cells; Th17; cells; NKT cells; MAIT cells;
D O I
10.1111/j.1523-5378.2008.00559.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Infection by the gastroduodenal pathogen Helicobacter pylori elicits a complex immunologic response in the mucosa involving neutrophils, plasma cells, eosinophils, and lymphocytes, of which T cells are the principal orchestrators of immunity. While so-called classical T cells (e.g. T-helper cells) that are activated by peptide fragments presented on antigen-presenting cells have received much attention in H. pylori infection, there exists a diverse array of other T cell populations that are potentially important for the outcome of the ensuing immune response, some of which have not been extensively studied in H. pylori infection. Pathogen-specific regulatory T cells that control and prevent the development of immunopathology associated with H. pylori infection have been investigated, but these cells can also benefit the bacterium in helping to prolong the chronicity of the infection by suppressing protective immune responses. An overlooked T cell population, the more recently described Th17 cells, may play a role in H. pylori-induced inflammation, due to triggering responses that ultimately lead to the recruitment of polymorphs, including neutrophils. The so-called innate or unconventional T cells, that include two conserved T cell subsets expressing invariant antigen-specific receptors, the CD1d-restricted natural killer T cells which are activated by glycolipids, and the mucosal-associated invariant T cells which play a role in defense against orally acquired pathogens in the intestinal mucosa, have only begun to receive attention. A greater knowledge of the range of T cell responses induced by H. pylori is required for a deeper understanding of the pathogenesis of this bacterium and its ability to perpetuate chronic infection, and could reveal new strategies for therapeutic exploitation.
引用
收藏
页码:1 / 19
页数:19
相关论文
共 200 条
[1]   Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17 [J].
Aggarwal, S ;
Ghilardi, N ;
Xie, MH ;
de Sauvage, FJ ;
Gurney, AL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (03) :1910-1914
[2]  
Aggarwal S, 2002, J LEUKOCYTE BIOL, V71, P1
[3]   Protection against Helicobacter pylori infection following immunization is IL-12-dependent and mediated by Th1 cells [J].
Akhiani, AA ;
Pappo, J ;
Kabok, Z ;
Schön, K ;
Gao, W ;
Franzén, LE ;
Lycke, N .
JOURNAL OF IMMUNOLOGY, 2002, 169 (12) :6977-6984
[4]   Helicobacter pylori persistence:: An overview of interactions between H-pylori and host immune defenses [J].
Algood, Holly M. Scott ;
Cover, Timothy L. .
CLINICAL MICROBIOLOGY REVIEWS, 2006, 19 (04) :597-+
[5]   The neutrophil-activating protein of Helicobacter pylori promotes Th1 immune responses [J].
Amedei, A ;
Cappon, A ;
Codolo, G ;
Cabrelle, A ;
Polenghi, A ;
Benagiano, M ;
Tasca, E ;
Azzurri, A ;
D'Elios, MM ;
Del Prete, G ;
de Bernard, M .
JOURNAL OF CLINICAL INVESTIGATION, 2006, 116 (04) :1092-1101
[6]  
[Anonymous], 1994, IARC Monogr Eval Carcinog Risks Hum, V61, P1
[7]   Cutting edge: Carbohydrate profiling identifies new pathogens that interact with dendritic cell-specific ICAM-3-grabbing nonintegrin on dendritic cells [J].
Appelmelk, BJ ;
van Die, I ;
van Vliet, SJ ;
Vandenbroucke-Grauls, CMJE ;
Geijtenbeek, TBH ;
van Kooyk, Y .
JOURNAL OF IMMUNOLOGY, 2003, 170 (04) :1635-1639
[8]   Phase variation in Helicobacter pylori lipopolysaccharide due to changes in the lengths of poly(C) tracts in α3-fucosyltransferase genes [J].
Appelmelk, BJ ;
Martin, SL ;
Monteiro, MA ;
Clayton, CA ;
McColm, AA ;
Zheng, PY ;
Verboom, T ;
Maaskant, JJ ;
Van den Eijnden, DH ;
Hokke, CH ;
Perry, MB ;
Vandenbroucke-Grauls, CMJE ;
Kusters, JG .
INFECTION AND IMMUNITY, 1999, 67 (10) :5361-5366
[9]  
Azuma T, 2003, CANCER RES, V63, P4516
[10]  
Bäckhed F, 2003, J INFECT DIS, V187, P829